AstraZeneca (AZN) announced the launch of AstraZeneca Direct, an online platform designed to create a way for eligible patients to access their prescribed medications at a transparent cash price with home delivery. AstraZeneca Direct will support people living with chronic conditions such as asthma, diabetes, heart failure and chronic kidney disease, and people seeking flu protection.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- Tempus AI price target raised to $95 from $80 at Guggenheim
- Trump announcement gives big pharma ‘light at end of the tunnel,’ says Jefferies
- U.S. Pharma Stocks Rise on Trump’s Fresh 100% Tariff Threat on Foreign Drugs
- Trump to impose 100% tariff on drugs unless manufacturer building U.S. plant
- AstraZeneca’s Promising New Study on AZD6621 for Prostate Cancer